Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 11 February 1977:
Vol. 195. no. 4278, pp. 577 - 580
DOI: 10.1126/science.835014
Prev | Table of Contents | Next

Articles

Science, Vol 195, Issue 4278, 577-580
Copyright © 1977 by American Association for the Advancement of Science

articles

Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors

RJ Bernacki and U Kim

Rats with transplantable spontaneously metastasizing mammary tumors have elevated levels of both serum sialoglycoconjugate and serum sialytransferase activity compared with normal female rats or rats with various nonmetastasizing mammary tumors. A direct relationship was observed between the amount of serum protein-bound sialic acid and serum sialyltransferase activity in all rats studied. Serum sialyltransferase activity in rats with a representative metastasizing mammary tumor, SMT-2A, was also correlated with tumor age. Microsomes prepared from the SMT-2A tumor have a sixfold higher sialyltransferase activity than do microsomes prepared from the nonmetastasizing mammary tumor MT-W9B. Normal rat liver microsomes have the same level of activity as microsomes prepared from livers of animals with either SMT-2A or MT-W9B tumors. The data indicate that spontaneously metastasizing mammary tumor cells have an increased production and release, perhaps through cell surface shedding, of a sialyltransferase. It is suggested that this sialyltransferase may increase the serum half-life of certain tumor-specific circulating glycoconjugates by increasing the content of protein-bound sialic acid and may thereby play a role in the immune escape mechanism of metastasizing tumor cells.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
In Vivo Cleavage of {alpha}2,6-Sialyltransferase by Alzheimer {beta}-Secretase.
S. Kitazume, K. Nakagawa, R. Oka, Y. Tachida, K. Ogawa, Y. Luo, M. Citron, H. Shitara, C. Taya, H. Yonekawa, et al. (2005)
J. Biol. Chem. 280, 8589-8595
   Abstract »    Full Text »    PDF »
The Hexapeptide Inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-Sialyltransferase as a Generic Inhibitor of Sialyltransferases.
K.-Y. Lee, H. G. Kim, M. R. Hwang, J. I. Chae, J. M. Yang, Y. C. Lee, Y. K. Choo, Y. I. Lee, S.-S. Lee, and S.-I. Do (2002)
J. Biol. Chem. 277, 49341-49351
   Abstract »    Full Text »    PDF »
Cell-Surface Galactosyltransferase Acts as a Modulator of Rat and Human Acinar Cell Proliferation.
M.G. Humphreys-Beher, T. Zelles, N. Maeda, K.R. Purushotham, N. Cassisi, and C.A. Schneyer (1990)
Advances in Dental Research 4, 45-60
   Abstract »    PDF »
Decrease of human serum fucosyltransferase as an indicator of successful tumor therapy.
C. Bauer, W. Reutter, K. Erhart, E Kottgen, and W Gerok (1978)
Science 201, 1232-1233
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)